David Gluckman, M.D.

Dr. Gluckman is vice chairman of investment banking and global head of Lazard’s healthcare group. He has been at Lazard since 1998, providing strategic and financial advice to senior executives and boards of directors at leading healthcare companies globally. He is currently an advisory board member of the Vagelos Program in Life Sciences and Management, jointly administered by the College of Arts & Sciences and the Wharton School at the University of Pennsylvania.

  • March 2021

Added to: X-37 LLC - S. San Francisco, CA

X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence tehnology from Atomwise Inc. to screen vast libraries of chemical compounds against high value pharmaceutical targets.